3/4
10:07 am
ymab
Rating for YMAB
Medium
Report
Rating for YMAB
3/4
08:43 am
ymab
Rating for YMAB
High
Report
Rating for YMAB
3/4
08:43 am
ymab
Rating for YMAB
High
Report
Rating for YMAB
2/12
06:18 pm
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock, up previously from $12.00.
Low
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock, up previously from $12.00.
2/12
06:18 pm
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock, up previously from $12.00.
Low
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock, up previously from $12.00.